US approval for Epidiolex fuels new hope for cannabinoid-based medicines

In June the US Food and Drug Administration approved the country’s first cannabinoid-based drug, Epidiolex, for treating seizures in two forms of severe epilepsy. Abi Millar asks what this milestone will mean for other cannabinoid-based medicines being developed in the country.

2018-09-17T13:09:55+00:00 26 July 2018|Health|